Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1179392 NEW YORK, NY
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,700,863
+$277,123 QoQ
Shares Held
252,964
+7.1% QoQ
Ownership
1.89%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 134 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. ANIK ranks #25 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 2,076,260 $349,932,860
2 BCRX
Biocryst Pharmaceuticals Inc
 6,775,349 $67,753,490
3 SUPN
Supernus Pharmaceuticals, Inc.
 1,184,378 $55,085,420
4 ALKS
Alkermes plc.
 1,038,311 $54,407,496
5 KNSA
Kiniksa Pharmaceuticals International, plc
 561,480 $35,906,646
6 ZTS
Zoetis Inc.
 386,428 $27,768,716
7 LQDA
Liquidia Corp
 266,829 $21,274,276
8 IRWD
Ironwood Pharmaceuticals Inc
 4,556,089 $19,181,134

All Filings in ANIK

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,700,863 252,964
2026-03-31 $3,423,740 236,120
2025-12-31 $2,246,894 233,808
2025-09-30 $751,257 79,921
2024-12-31 $199,100 12,096
2024-09-30 $526,999 21,336
2024-06-30 $711,773 28,100
2024-03-31 $1,200,658 47,270
2023-12-31 $1,365,582 60,264
2023-09-30 $328,148 17,614
2023-06-30 $1,677,009 64,550
2023-03-31 $1,390,191 48,405
2022-12-31 $1,853,907 62,632
2022-09-30 $779,521 32,753
2022-06-30 $1,458,969 65,366
2022-03-31 $1,212,235 48,277
2021-12-31 $1,922,458 53,655
2021-09-30 $2,790,574 65,568
2021-06-30 $5,018,393 115,925
2021-03-31 $4,600,418 112,783
2020-12-31 $2,364,110 52,234
2020-09-30 $1,597,929 45,152
2020-06-30 $1,038,857 27,534
2020-03-31 $811,850 28,082